A new study published in the JAMA said that hormonal therapy can help to ease the symptoms of menopause. The study also found ...
Researchers examined 453 menopausal women aged 40–65 with moderate or severe hot flushes who were unsuitable for hormone replacement therapy, after giving them 45mg of fezolinetant or placebo ...
An older form of hormone therapy taken to ease the symptoms of menopause could increase the risk of ovarian cancer, according to results released Thursday from two studies involving tens of ...
Women who start the menopause before the age of 40 are more likely to die young, new research suggests. Most women experience menopause between the ages of 45 and 55. But around one in 100 go ...
Researchers found un-immediate relatives – ie grandparents, aunts, uncles, nieces and nephews – were 1.5 times more likely to get colon cancer if their relative had started the menopause early ...
Moderate to severe hot flashes may triple the risk of metabolic dysfunction steatotic liver disease, a study suggests.
Research, by her menopause clinic Newson Health, found almost a third of women had between two and five medical appointments before their symptoms were diagnosed as linked to the perimenopause and ...
If exercise seems to trigger hot flashes, switching to lower-intensity activities could help reduce hot flash frequency.
A follow-up analysis shows that the benefits of hormone therapy for the treatment of menopause symptoms outweigh the risks ...
Fezolinetant reduces the frequency and severity of hot flushes during menopause for 24 weeks, without serious side effects, according to research presented at the 26th European Congress of ...